MSB 3.21% $1.13 mesoblast limited

Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS, page-505

  1. 397 Posts.
    lightbulb Created with Sketch. 299
    Good pick, updated timeline. We should have passed 30 days yesterday. Readout imminent.
    https://hotcopper.com.au/data/attachments/2716/2716065-be9ba8b24ab245349f79f40332b50316.jpg

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.